Author

Edward Livant

Observed names: E. Livant, Edward W Livant

Observed institutions: National Institutes of Health, Johns Hopkins University, University of Cape Town, University of Pittsburgh, University of the Witwatersrand, University of Washington, Fred Hutch Cancer Center, Magee-Womens Research Institute, National Institute of Allergy and Infectious Diseases, University of Pittsburgh Medical Center

ORCID: 0000-0003-4302-3950

Observed ORCID: 0000-0003-4302-3950

OpenAlex ID: A5069834552

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

2016 · Jared M. Baeten, Thesla Palanee-Phillips, et al. · New England Journal of Medicine · 788

PDF

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

2016 · Jared M. Baeten, Thesla Palanee-Phillips, et al. · Obstetrical & Gynecological Survey · 373

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

2011 · Ian McGowan, Kailazarid Gomez, et al. · AIDS · 126

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

2021 · Jared M Baeten, Thesla Palanee-Phillips, et al. · The Lancet HIV · 110

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

2023 · Gonasagrie Nair, Connie Celum, et al. · The Lancet HIV · 64

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations

2017 · Catherine A. Koss, Peter Bacchetti, et al. · AIDS Research and Human Retroviruses · 58

The fourth generation Alere TM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples

2017 · Edward Livant, Amy Heaps, et al. · Journal of Clinical Virology · 38

Ethnic variation in certain hematological and biochemical reference intervals in a south Indian healthy adult population

2007 · M. Sundaram, J. Mohanakrishnan, et al. · European Journal of Internal Medicine · 38

Factors associated with bone mineral density in healthy African women

2015 · for the MTN-003B Protocol Team, Nyaradzo M. Mgodi, et al. · Archives of Osteoporosis · 22

Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women

2024 · Sujatha Srinivasan, Barbra A Richardson, et al. · The Journal of Infectious Diseases · 21

PDF

Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial

2017 · Marla J. Husnik, Elizabeth R. Brown, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 16

A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035)

2023 · Jose A. Bauermeister, Clara Dominguez Islas, et al. · PLoS ONE · 15

PDF

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial

2025 · Lisa M Noguchi, Maxensia Owor, et al. · The Lancet HIV · 14

Establishment of T-lymphocyte subset reference intervals in a healthy adult population in Chennai, India.

2009 · K G Murugavel, P Balakrishnan, et al. · PubMed · 13

Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention

2021 · Marla J. Husnik, Elizabeth R. Brown, et al. · AIDS and Behavior · 12

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring

2018 · Sharon A Riddler, Jennifer E Balkus, et al. · Clinical Infectious Diseases · 11

Association of Tenofovir (TFV) Detection with Reduced Risk of Herpes Simplex virus Type-2 (HSV-2) Acquisition in the VOICE (MTN 003) Study

2014 · Jeanne Marrazzo, Lorna Rabe, et al. · AIDS Research and Human Retroviruses · 11

Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015

2016 · Sharon A. Riddler, Marla Husnik, et al. · HIV Clinical Trials · 8

PDF

Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence

2024 · Marla J. Husnik, Renee Heffron, et al. · AIDS and Behavior · 4

PDF

HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial

2017 · Sharon A. Riddler, Marla Husnik, et al. · PLoS ONE · 4

PDF

Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

2025 · Lee Fairlie, Daniel W Szydlo, et al. · The Lancet HIV · 3

Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial

2026 · Felix G Mhlanga, Daniel W Szydlo, et al. · The Lancet HIV · 2

Prevalent and Incident Gonorrhea and Chlamydia Infections among Oral Contraceptive and Depot Medroxyprogesterone Acetate Users in MTN-003 (VOICE)

2014 · Flavia Matovu Kiweewa, Lisa Noguchi, et al. · AIDS Research and Human Retroviruses · 1

A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)

2023 · Seul Ki Choi, José Bauermeister, et al. · BMC Public Health

PDF

P587 Association between vaginal bacteria and HIV acquisition risk among african women participating in the VOICE study

2019 · Sujatha Srinivasan, Barbra Richardson, et al. · Sexually Transmitted Infections

PDF

Works count: 26

Citation count: 1,862

H-index: 14

I10-index: 18